Developer docs
API playgroundTry for free, no card

Search company profiles

Chicago Research Center

Full company profile

uuid00058oa

Namestring
Chicago Research Center
Legal namestring
Chicago Research Center
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Chicago Research Center is a single-site clinical research organization founded in 2005 and headquartered in Chicago's Portage Park neighborhood (3401 N. Central Avenue), operating as a Phase I-IV clinical trial site serving pharmaceutical sponsors, biotechnology companies, and Contract Research Organizations (CROs). Since its founding the site has participated in more than 800 clinical trials across four primary therapeutic areas: sleep medicine (narcolepsy, insomnia, sleep apnea, shift work), psychiatric and neurological disorders (depression, PTSD, schizophrenia, bipolar, generalized anxiety disorder, OCD, panic disorder, Alzheimer's and related dementia, mild cognitive impairment, psychedelics), internal medicine (Type II diabetes, hypertension, pain, women's health, migraines), and ophthalmologic conditions. The site maintains a proprietary patient database of over 50,000 individuals concentrated in CNS and sleep indications, and is staffed by board-certified physicians, licensed clinicians, psychometricians, and dedicated research professionals.

Revenue is generated through contracted professional-services agreements with sponsors and CROs for the execution of clinical trial protocols. Patient recruitment is supported by a dedicated outreach infrastructure including the IMA website, a Patient Outreach Center with two phone lines, online pre-screening booking, and a Refer-a-Friend program. Pricing is not publicly disclosed; specific study compensation varies by protocol duration and procedures, and trial participants are compensated for time and travel.

On October 8, 2025, Chicago Research Center was acquired by IMA Group, a private-equity-backed clinical research platform (with Centre Partners as financial backer), and rebranded as IMA Clinical Research Chicago. The acquisition marked IMA Group's first entry into sleep research and integrated CRC into a national network spanning 15+ locations across Arizona, Florida, Illinois, Louisiana, North Carolina, New Jersey, New Mexico, Nevada, New York, and Texas, enabling multi-site trial execution and broader patient recruitment scale.

Short descriptiontext

Chicago Research Center is a Chicago-based Phase I-IV clinical trial site founded in 2005, specializing in CNS, sleep, psychiatric, psychedelic, vaccine, and general medicine trials for pharma, biotech, and CRO sponsors. It was acquired by IMA Group in October 2025 and rebranded as IMA Clinical Research Chicago.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, CNS clinical trials, sleep medicine research, psychiatric clinical trials, patient recruitment services
Industry4 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
SECONDARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAIAAAF
Neurology & Psychiatry (CNS) Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Research Services
TypeProfessional Services
Description

Conducting clinical trials for pharmaceutical and biotechnology companies across psychiatric, sleep, psychedelics, vaccine, and general medicine indications. Revenue is generated through contracted research agreements with sponsors and CROs.

imaresearch.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Chicago Research Center (now operating as IMA Clinical Research Chicago) is a dedicated clinical research site that conducts Phase I-IV clinical trials on behalf of pharmaceutical, biotechnology, and CRO sponsors. Since 2005, the site has participated in over 800 clinical trials spanning psychiatric, sleep, psychedelics, vaccine, and general medicine indications, recruiting participants from a proprietary database of more than 50,000 patients. The site operates from Portage Park, Chicago, staffed by board-certified physicians, licensed clinicians, psychometricians, and dedicated research professionals.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Chicago Research Center operates as a clinical research site organization offering Phase I-IV clinical trial services. The organization provides a unified research platform through its network of research sites, offering patient database access, psychometric testing capabilities, and dedicated research professionals. IMA Clinical Research Chicago (formerly Chicago Research Center) has conducted over 800 clinical trials since 2005, with specialization across four main therapeutic areas: Sleep Medicine (including narcolepsy, insomnia, sleep apnea), Psychiatric/Neurological Disorders (depression, PTSD, schizophrenia, psychedelics), Internal Medicine (diabetes, hypertension, pain management), and Ophthalmologic conditions. The organization was acquired by IMA Group in October 2025, expanding IMA's national network and marking its first entry into sleep research.

Product and service1 record
1IMA Clinical Research Chicago (formerly Chicago Research Center)
CategoryClinical Research Services
Description

Clinical research site offering Phase I-IV clinical trials across psychiatric, sleep, psychedelics, vaccine, and general medicine indications for pharmaceutical, biotechnology, and CRO sponsors. Operates from Portage Park serving the greater Chicagoland area and has participated in over 800 clinical trials since 2005.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Largest global CRO with an embedded site network and site solutions offering. Comparable as a competitor for sponsor trial awards; CRC's IMA affiliation competes with IQVIA's site network strategy.

TypeBroad incumbent
Description

Mid-to-large global CRO running full-service clinical trials across all phases and therapeutic areas. Comparable as a competing buyer of sponsor protocol awards, though at much greater scale and with broader service scope.

TypeDirect peer
Description

One of the largest SMO networks in the U.S. operating multi-specialty clinical research sites. Directly comparable to IMA Group/CheRC's thesis of consolidating fragmented research sites into a national network serving pharma/biotech sponsors.

TypeDirect peer
Description

Multi-site clinical research organization operating dedicated research centers across the U.S. Comparable as a similar-stage SMO focused on therapeutic specialization and patient recruitment capabilities.

TypeDirect peer
Description

Integrated research organization embedding clinical trials within healthcare provider systems. Comparable to CRC's model of running trial operations with dedicated research professionals and patient recruitment infrastructure.

TypeDirect peer
Description

Clinical research site network with deep specialization in CNS, analgesia, and other complex indications. Strongly comparable given CRC's CNS/sleep focus and the multi-site operating model CRC now sits within at IMA.

7Clēnera
TypeDirect peer
Description

Niche SMO with clinical research site operations and patient-recruitment focus on CNS indications; operates with a similar specialty-site model to CRC and is increasingly part of clinical research site consolidation trends.

TypeBroad incumbent
Description

Global CRO with significant CNS and clinical trial site management capabilities. Comparable as a sponsor-facing competitor that bids for the same Phase II/III protocols CRC targets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Chicago Research Center

Clinical Research Serviceschicagoresearchcenter.com

Chicago Research Center is a Chicago-based Phase I-IV clinical trial site founded in 2005, specializing in CNS, sleep, psychiatric, psychedelic, vaccine, and general medicine trials for pharma, biotech, and CRO sponsors. It was acquired by IMA Group in October 2025 and rebranded as IMA Clinical Research Chicago.

What Chicago Research Center does

Chicago Research Center is a single-site clinical research organization founded in 2005 and headquartered in Chicago's Portage Park neighborhood (3401 N. Central Avenue), operating as a Phase I-IV clinical trial site serving pharmaceutical sponsors, biotechnology companies, and Contract Research Organizations (CROs). Since its founding the site has participated in more than 800 clinical trials across four primary therapeutic areas: sleep medicine (narcolepsy, insomnia, sleep apnea, shift work), psychiatric and neurological disorders (depression, PTSD, schizophrenia, bipolar, generalized anxiety disorder, OCD, panic disorder, Alzheimer's and related dementia, mild cognitive impairment, psychedelics), internal medicine (Type II diabetes, hypertension, pain, women's health, migraines), and ophthalmologic conditions. The site maintains a proprietary patient database of over 50,000 individuals concentrated in CNS and sleep indications, and is staffed by board-certified physicians, licensed clinicians, psychometricians, and dedicated research professionals.

Revenue is generated through contracted professional-services agreements with sponsors and CROs for the execution of clinical trial protocols. Patient recruitment is supported by a dedicated outreach infrastructure including the IMA website, a Patient Outreach Center with two phone lines, online pre-screening booking, and a Refer-a-Friend program. Pricing is not publicly disclosed; specific study compensation varies by protocol duration and procedures, and trial participants are compensated for time and travel.

On October 8, 2025, Chicago Research Center was acquired by IMA Group, a private-equity-backed clinical research platform (with Centre Partners as financial backer), and rebranded as IMA Clinical Research Chicago. The acquisition marked IMA Group's first entry into sleep research and integrated CRC into a national network spanning 15+ locations across Arizona, Florida, Illinois, Louisiana, North Carolina, New Jersey, New Mexico, Nevada, New York, and Texas, enabling multi-site trial execution and broader patient recruitment scale.

Chicago Research Center firmographics

Firmographics
Name
Chicago Research Center
Legal name
Chicago Research Center
Website
https://chicagoresearchcenter.com
Company type
Private
Founded year
2005
Operating status
Acquired
Headcount range
1–10 employees
Short description
Chicago Research Center is a Chicago-based Phase I-IV clinical trial site founded in 2005, specializing in CNS, sleep, psychiatric, psychedelic, vaccine, and general medicine trials for pharma, biotech, and CRO sponsors. It was acquired by IMA Group in October 2025 and rebranded as IMA Clinical Research Chicago.
Ownership category
akta.pro rank

Chicago Research Center industry classification

Industry
Product category
Clinical Research Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
SECONDARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAIAAAF
Neurology & Psychiatry (CNS) Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Clinical research services
  • CNS clinical trials
  • Sleep medicine research
  • Psychiatric clinical trials
  • Patient recruitment services

Where Chicago Research Center is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Chicago Research Center business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Research Services: Conducting clinical trials for pharmaceutical and biotechnology companies across psychiatric, sleep, psychedelics, vaccine, and general medicine indications. Revenue is generated through contracted research agreements with sponsors and CROs.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Chicago Research Center product offering

Product offering

Core offering

Chicago Research Center (now operating as IMA Clinical Research Chicago) is a dedicated clinical research site that conducts Phase I-IV clinical trials on behalf of pharmaceutical, biotechnology, and CRO sponsors. Since 2005, the site has participated in over 800 clinical trials spanning psychiatric, sleep, psychedelics, vaccine, and general medicine indications, recruiting participants from a proprietary database of more than 50,000 patients. The site operates from Portage Park, Chicago, staffed by board-certified physicians, licensed clinicians, psychometricians, and dedicated research professionals.

Product overview

Chicago Research Center operates as a clinical research site organization offering Phase I-IV clinical trial services. The organization provides a unified research platform through its network of research sites, offering patient database access, psychometric testing capabilities, and dedicated research professionals. IMA Clinical Research Chicago (formerly Chicago Research Center) has conducted over 800 clinical trials since 2005, with specialization across four main therapeutic areas: Sleep Medicine (including narcolepsy, insomnia, sleep apnea), Psychiatric/Neurological Disorders (depression, PTSD, schizophrenia, psychedelics), Internal Medicine (diabetes, hypertension, pain management), and Ophthalmologic conditions. The organization was acquired by IMA Group in October 2025, expanding IMA's national network and marking its first entry into sleep research.

Differentiator

Problem solved

Functional benefit

Products and services

  • IMA Clinical Research Chicago (formerly Chicago Research Center) Clinical research site offering Phase I-IV clinical trials across psychiatric, sleep, psychedelics, vaccine, and general medicine indications for pharmaceutical, biotechnology, and CRO sponsors. Operates from Portage Park serving the greater Chicagoland area and has participated in over 800 clinical trials since 2005.

Companies that use Chicago Research Center

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Chicago Research Center technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Chicago Research Center partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Chicago Research Center competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: Largest global CRO with an embedded site network and site solutions offering. Comparable as a competitor for sponsor trial awards; CRC's IMA affiliation competes with IQVIA's site network strategy.
  • Medpace: Mid-to-large global CRO running full-service clinical trials across all phases and therapeutic areas. Comparable as a competing buyer of sponsor protocol awards, though at much greater scale and with broader service scope.
  • Parexel International: Global CRO with significant CNS and clinical trial site management capabilities. Comparable as a sponsor-facing competitor that bids for the same Phase II/III protocols CRC targets.

Direct peers

  • Velocity Clinical Research: One of the largest SMO networks in the U.S. operating multi-specialty clinical research sites. Directly comparable to IMA Group/CheRC's thesis of consolidating fragmented research sites into a national network serving pharma/biotech sponsors.
  • Accel Research Sites: Multi-site clinical research organization operating dedicated research centers across the U.S. Comparable as a similar-stage SMO focused on therapeutic specialization and patient recruitment capabilities.
  • Javara Research: Integrated research organization embedding clinical trials within healthcare provider systems. Comparable to CRC's model of running trial operations with dedicated research professionals and patient recruitment infrastructure.
  • CenExel: Clinical research site network with deep specialization in CNS, analgesia, and other complex indications. Strongly comparable given CRC's CNS/sleep focus and the multi-site operating model CRC now sits within at IMA.
  • Clēnera: Niche SMO with clinical research site operations and patient-recruitment focus on CNS indications; operates with a similar specialty-site model to CRC and is increasingly part of clinical research site consolidation trends.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Chicago Research Center social profiles

Digital presence

Chicago Research Center financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Chicago Research Center leadership team

Management profile

Number of profiles

Chicago Research Center funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Chicago Research Center M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chicago Research Center

What does Chicago Research Center do?

Chicago Research Center (now operating as IMA Clinical Research Chicago) is a dedicated clinical research site that conducts Phase I-IV clinical trials on behalf of pharmaceutical, biotechnology, and CRO sponsors. Since 2005, the site has participated in over 800 clinical trials spanning psychiatric, sleep, psychedelics, vaccine, and general medicine indications, recruiting participants from a proprietary database of more than 50,000 patients. The site operates from Portage Park, Chicago, staffed by board-certified physicians, licensed clinicians, psychometricians, and dedicated research professionals.

Is Chicago Research Center a public or private company?

Chicago Research Center is a private company. It is classified as corporate owned and is currently acquired.

When was Chicago Research Center founded?

Chicago Research Center was founded in 2005. It employs 1 to 10 people.

Where is Chicago Research Center based?

Chicago Research Center is headquartered in Chicago, United States, in the North America region.

How does Chicago Research Center make money?

One revenue line is on record: clinical Research Services.

Who are Chicago Research Center's main competitors?

Broad incumbents on record are IQVIA, Medpace and Parexel International. Direct peers are Velocity Clinical Research, Accel Research Sites, Javara Research, CenExel and Clēnera.

Does Chicago Research Center have an API?

No public API is recorded for Chicago Research Center.

What industry is Chicago Research Center in?

Chicago Research Center's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAC, Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Castle PlacementTop 10 HealthCare Services Capital Raises and Investors in the U.S.This article summarizes ten capital raising and acquisition transactions within the U.S. HealthCare Services sector between October 1st and 15th, 2025. Key events include The IMA Group acquiring Chicago Research Center and Millennium Physician Group acquiring IMA Medical Group via leveraged buyouts, alongside various venture capital investments in firms like Foundation Health and Elevation Autism Center.BioSpaceThe IMA Group Clinical Research Division Continues Expansion with Acquisition of Chicago Research CenterThe IMA Group announced the acquisition of Chicago Research Center (CRC), an independent clinical research site specializing in central nervous system, sleep disorders, mood and memory disorders, pain, and general medicine trials. CRC, founded in 2005 and operating an 8,000-square-foot facility with a six-bed sleep lab, brings over 125 completed studies and a database of more than 50,000 patients to IMA's national network. The acquisition marks IMA Clinical Research's entry into sleep research—a growing therapeutic area where an estimated 50 to 70 million Americans suffer from sleep disorders—and represents IMA's ninth clinical research acquisition over the past four years and sixth dedicated CNS research site.TheimagroupThe IMA Group Acquires Chicago Research CenterThe IMA Group announced the acquisition of Chicago Research Center (CRC), an independent Chicago-based clinical research site specializing in Phase I–IV trials for central nervous system disorders, sleep disorders, mood and memory disorders, pain, and general medicine. CRC operates an 8,000-square-foot facility with a six-bed sleep lab and has conducted more than 125 studies supported by a database of over 50,000 patients since its founding in 2005. The acquisition marks IMA Clinical Research's entry into sleep research and represents its sixth dedicated CNS research site and ninth Clinical Research acquisition over the past four years.YahooThe IMA Group Clinical Research Division Continues Expansion with Acquisition of Chicago Research CenterThe IMA Group announced the acquisition of Chicago Research Center (CRC), a Chicago-based clinical research site specializing in CNS and sleep disorder trials, expanding IMA Clinical Research's national network. CRC, founded in 2005 with an 8,000-square-foot facility and a database of over 50,000 patients, brings expertise in Phase I-IV trials and introduces sleep research capabilities to IMA for the first time. The acquisition aims to expand trial capacity, strengthen sponsor relationships, and address unmet needs in sleep disorders affecting an estimated 50-70 million Americans.CentrepartnersCentre Partners Management LLCThe IMA Group announced the acquisition of Chicago Research Center (CRC), a Chicago-based clinical research site specializing in central nervous system (CNS) and sleep disorder research, on October 7, 2025. CRC will continue operating under its current name and leadership, bringing its 8,000-square-foot facility with a six-bed sleep lab and database of more than 50,000 patients to IMA's national network of over 150 sites. This is IMA's ninth Clinical Research acquisition over four years and marks the company's strategic entry into sleep research, an area identified as a growing public health priority affecting an estimated 50 to 70 million Americans.